The collagenous wound healing scar in the injured central nervous system inhibits axonal regeneration

Advances in Experimental Medicine and Biology

Volumn 557, Issue , 2005, Pages 177-190

  Hermanns, Susanne ^a   Klapka, Nicole ^a   Gasis, Marcia ^a   Müller, Hans Werner ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN TYPE 4; CYCLIC AMP; IRON CHELATING AGENT;

BASEMENT MEMBRANE; BIOSYNTHESIS; BRAIN DAMAGE; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM TUMOR; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVE FIBER TRANSECTION; NERVE POTENTIAL; NEUROFILAMENT; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PYRAMIDAL TRACT; REMYELINIZATION; REVIEW; SCAR FORMATION; SPINAL CORD LESION; SYNAPSE; WOUND HEALING;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; AXONS; AXOTOMY; BASEMENT MEMBRANE; CENTRAL NERVOUS SYSTEM; CHELATING AGENTS; COLLAGEN; PERIPHERAL NERVOUS SYSTEM; REGENERATION; WOUND HEALING;

EID: 33744544911     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (36)

1. Stichel, CC and Müller, HW. Experimental strategies to promote axonal regeneration. Prog Neurobiol 1998; 56: 119-148.
2. Schnell L, Schwab ME. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 1990; 343: 269-272.
3. Cai D, Shen Y, De BM et al. Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism. 1999; Neuron 22: 89-101.
4. Snow DM, Lemmon V, Carrino DA et al. Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp Neurol 1990; 109: 111-130.
5. Bovolenta P, Fernaud-Espinosa I, Mendez-Otero R et al. Neurite outgrowth inhibitor of gliotic brain tissue. Mode of action and cellular localization, studied with specific monoclonal antibodies. Eur J Neurosci 1997; 9: 977-989.
6. Moon LD, Brecknell JE, Franklin RJ et al. Robust regeneration of CNS axons through a track depleted of CNS glia. Exp Neurol 2000; 161: 49-66.
7. Pasterkamp RJ, De WF, Giger RJ et al. Role for semaphorin III and its receptor neuropilin-1 in neuronal regeneration and scar formation? Prog Brain Res 1998; 117: 151-170.
8. Bundesen LQ, Janis LS, Bregman BS et al. Alterations of EphB2 proteins following spinal cord injury in the adult rat. 2000; Abstract Book of the 30st annual meeting of the Society for Neuroscience.
9. Fidler PS, Schuette K, Asher RA et al. Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2. J Neurosci 1999; 19: 8778-8788.
10. Bovolenta P, Fernaud-Espinosa I. Nervous system proteoglycans as modulators of neurite outgrowth. Prog Neurobiol 2000; 61: 113-132.
11. Probstmeier R, Stichel CC, Müller, HW. Chondroitin sulfates expressed on oligodendrocyte-derived tenascin-R are involved in neural cell recognition-functional implications during CNS development and regeneration. J Neurosci Res 2000; 60: 21-36.
12. Becker T, Anliker B, Becker CG et al. Tenascin-R inhibits regrowth of optic fibers in vitro and persists in the optic nerve of mice after injury. GLIA 2000; 29: 330-346.
13. Asher RA, Morgenstern DA, Moon LD et al. Chondroitin sulphate proteoglycans: inhibitory components of the glial scar. Prog Brain Res 2001; 132: 611-619.
14. Bradbury EJ, Moon LD, Popat RJ et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2001; 416: 636-640.
15. Stichel CC, Niermann H, D'Urso D et al. Basal membrane-depleted scar in lesioned CNS: characteristics and relationships with regenerating axons. Neuroscience 1999; 93: 321-333.
16. Ramon y Cajal S. Degeneration and regeneration of the nervous system. 1928. New York, Hafner.
17. Matinian LA, Andreasian AS (1973) Enzyme therapy in organic lesions of the spinal cord. Akademia Nauk Armenian SSR, 94pp (English translation: Los Angeles, Brain Information Service, University of California, 1976, 156pp).
18. Feringa ER, Kowalski TF, Vahlsing HL et al. Enzyme treatment of spinal cord transected rats. Ann Neurol 1979; 5: 203-206.
19. Matthews MA, St Onge MF, Faciane CL et al. Spinal cord transection: a quantitative analysis of elements of the connective tissue matrix formed within the site of lesion following administration of piromen, cytoxan or trypsin. Neuropathol Appl Neurobiol 1979; 5: 161-180.
20. Guth L, Albuquerque EX, Deshpande SS et al. Ineffectiveness of enzyme therapy on regeneration in the transected spinal cord of the rat. J Neurosurg 1980; 52: 73-86.
21. Kagan HM. Intra- and extracellular enzymes of collagen biosynthesis as biological and chemical targets in the control of fibrosis. Acta Trop 2000; 77: 147-152.
22. Hermanns S, Müller HW. Preservation and detection of lesion-induced collagenous scar in the CNS depend on the method of tissue processing. Brain Res Protoc 2001; 7: 162-167.
23. Hermanns S, Klapka N, Müller HW. The collagenous lesion scar-an obstacle for axonai regeneration in brain and spinal cord injury. Restor Neurol Neurosci 2001a; 19: 139-148.
24. Carbonell AL, Boya J. Ultrastructural study on meningeal regeneration and meningo-glial relationships after cerebral stab wound in the adult rat. Brain Res 1988; 439: 337-344.
25. Halfter W, Liverani D, Vigny M et al. Deposition of extracellular matrix along the pathways of migrating fibroblasts. Cell Tissue Res 1990; 262: 467-481.
26. Eckes B, Zigrino P, Kessler D et al. Fibroblast-matrix interactions in wound healing and fibrosis. Matrix Biol 2000; 19: 325-332.
27. Hermanns S, Reiprich P, Müller HW. A reliable method to reduce collagen scar formation in the lesioned rat spinal cord. J Neurosci Methods 2001b; 110: 141-146.
28. Liesi P, Kauppila T. Induction of type IV collagen and other basement-membrane-associated proteins after spinal cord injury of the adult rat may participate in formation of the glial scar. Exp Neurol 2002; 173: 31-45.
29. Shearer MC, Fawcett JW. The astrocyte/meningeal cell interface-a barrier to successful nerve regeneration? Cell Tissue Res 2001; 305: 267-273.
30. Duncan MR, Frazier KS, Abramson S et al. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEB J 1999; 13: 1774-1786.
31. Madri JA, Reidy MA, Kocher O et al. Endothelial cell behavior after denudation injury is modulated by transforming growth factor-beta1 and fibronectin. Lab Invest 1989; 60: 755-765.
32. Grotendorst GR. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 1997; 8: 171-179.
33. Bradham DM, Igarashi A, Potter RL et al. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1992; 114: 1285-1294.
34. Frazier K, Williams S, Kothapalli D et al. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996; 107: 404-411.
35. Kothapalli D, Hayashi N, Grotendorst GR. Inhibition of TGF-beta-stimulated CTGF gene expression and anchorage-independent growth by cAMP identifies a CTGF-dependent restriction point in the cell cycle. FASEB J 1998; 12: 1151-1161.
36. Ramon-Cueto A, Cordero MI, Santos-Benito FF et al. Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 2000; 25: 425-435.